Literature DB >> 10797405

CTG triplet repeat expansion in a laryngeal carcinoma from a patient with myotonic dystrophy.

R Osanai1, M Kinoshita, K Hirose, T Homma, I Kawabata.   

Abstract

A 66-year-old Japanese man with myotonic dystrophy (DM) underwent total laryngectomy for laryngeal carcinoma. The size of the expanded DNA fragment (EF) from the leukocytes and normal laryngeal tissues of this patient was only slightly longer than that in normal subjects. EF, however, was markedly longer in the laryngeal carcinoma. These findings support the hypothesis that elongation of the CTG repeat in the DM kinase gene occurs during acquired cell proliferation. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10797405     DOI： 10.1002/(sici)1097-4598(200005)23:5<804::aid-mus19>3.0.co;2-e

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


  7 in total

1.  Cancer risk among patients with myotonic muscular dystrophy.

Authors:  Shahinaz M Gadalla; Marie Lund; Ruth M Pfeiffer; Sanne Gørtz; Christine M Mueller; Richard T Moxley; Sigurdur Y Kristinsson; Magnus Björkholm; Fatma M Shebl; James E Hilbert; Ola Landgren; Jan Wohlfahrt; Mads Melbye; Mark H Greene
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

2.  Imaging of the thymus in myotonic dystrophy type 1.

Authors:  Andrea Mignarri; Francesco Gentili; Francesco Masia; Angelo Genua; Silvia Cenciarelli; Paola Brunori; Maria Antonietta Mazzei; Alessandro Malandrini; Antonio Federico; Francesco Giuseppe Mazzei; Maria Teresa Dotti
Journal:  Neurol Sci       Date:  2017-11-25       Impact factor: 3.307

3.  Correlates of tumor development in patients with myotonic dystrophy.

Authors:  Maya Das; Richard T Moxley; James E Hilbert; William B Martens; Lisa Letren; Mark H Greene; Shahinaz M Gadalla
Journal:  J Neurol       Date:  2012-05-23       Impact factor: 4.849

4.  A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy.

Authors:  Diana Abbott; Nicholas E Johnson; Lisa A Cannon-Albright
Journal:  Muscle Nerve       Date:  2016-07-07       Impact factor: 3.217

5.  Replication inhibitors modulate instability of an expanded trinucleotide repeat at the myotonic dystrophy type 1 disease locus in human cells.

Authors:  Zhi Yang; Rachel Lau; Julien L Marcadier; David Chitayat; Christopher E Pearson
Journal:  Am J Hum Genet       Date:  2003-10-21       Impact factor: 11.025

Review 6.  Hypothesis: neoplasms in myotonic dystrophy.

Authors:  Christine M Mueller; James E Hilbert; William Martens; Charles A Thornton; Richard T Moxley; Mark H Greene
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

7.  Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity.

Authors:  Rotana Alsaggaf; Diane Marie M St George; Min Zhan; Ruth M Pfeiffer; Youjin Wang; Kathryn R Wagner; Mark H Greene; Sania Amr; Shahinaz M Gadalla
Journal:  JNCI Cancer Spectr       Date:  2018-12-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.